Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 20;7(1):e12189.
doi: 10.1002/trc2.12189. eCollection 2021.

Identifying relevant outcomes in the progression of Alzheimer's disease; what do patients and care partners want to know about prognosis?

Affiliations

Identifying relevant outcomes in the progression of Alzheimer's disease; what do patients and care partners want to know about prognosis?

Arenda Mank et al. Alzheimers Dement (N Y). .

Abstract

Background: Prognostic studies in the context of Alzheimer's disease (AD) mainly predicted time to dementia. However, it is questionable whether onset of dementia is the most relevant outcome along the AD disease trajectory from the perspective of patients and their care partners. Therefore, we aimed to identify the most relevant outcomes from the viewpoint of patients and care partners.

Methods: We used a two-step, mixed-methods approach. As a first step we conducted four focus groups in the Netherlands to elicit a comprehensive list of outcomes considered important by patients (n = 12) and care partners (n = 14) in the prognosis of AD. The focus groups resulted in a list of 59 items, divided into five categories. Next, in an online European survey, we asked participants (n = 232; 99 patients, 133 care partners) to rate the importance of all 59 items (5-point Likert scale). As participants were likely to rate a large number of outcomes as "important" (4) or "very important" (5), we subsequently asked them to select the three items they considered most important.

Results: The top-10 lists of items most frequently mentioned as "most important" by patients and care partners were merged into one core outcome list, comprising 13 items. Both patients and care partners selected outcomes from the category "cognition" most often, followed by items in the categories "functioning and dependency" and "physical health." No items from the category "behavior and neuropsychiatry" and "social environment" ended up in our core list of relevant outcomes.

Conclusion: We identified a core list of outcomes relevant to patients and care partner, and found that prognostic information related to cognitive decline, dependency, and physical health are considered most relevant by both patients and their care partners.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

FIGURE 1
FIGURE 1
Percentage of participants who selected the item as important. A, Patients (n = 99). B, Care partners (n = 133). Figures show how frequently every item, grouped by category, was selected as one of the three most important outcomes by patients (A) and care partners (B). The items corresponding to each number can be found in the supporting information. The asterisks indicate the 10 items most frequently identified as most important by patients and by care partners, included in the core item list. Because seven items overlap, the core list comprises of 13 items

References

    1. Scheltens P, Blennow K, Breteler MM, et al. Alzheimer's disease. Lancet (London, England). 2016;388(10043):505‐517. - PubMed
    1. Schmidt‐Richberg A, Ledig C, Guerrero R, Molina‐Abril H, Frangi A, Rueckert D. Learning biomarker models for progression estimation of alzheimer's disease. PLoS One. 2016;11(4):e0153040. - PMC - PubMed
    1. Kunneman M, Smets EMA, Bouwman FH, et al. Clinicians' views on conversations and shared decision making in diagnostic testing for Alzheimer's disease: the ABIDE project. Alzheimers Dement (New York, N Y). 2017;3(3):305‐313. - PMC - PubMed
    1. Neumann PJ, Cohen JT, Hammitt JK, et al. Willingness‐to‐pay for predictive tests with no immediate treatment implications: a survey of US residents. Health Econ. 2012;21(3):238‐251. - PubMed
    1. Neumann PJ, Hammitt JK, Mueller C, et al. Public attitudes about genetic testing for Alzheimer's disease. Health Aff (Millwood). 2001;20(5):252‐264. - PubMed

LinkOut - more resources